A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J. Ashton, Oskar Hansson, Alexander Santillo et al.|Nature Communications|2021Cited by 554
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseJoel Simrén, Nicholas J. Ashton, Antoine Leuzy et al.|Alzheimer s & Dementia|2021Cited by 354
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer diseaseAnnapaola Prestia, Giovanni B. Frisoni, Anna Caroli et al.|Neurology|2013Cited by 189
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advancesJoyce R. Chong, Mitchell K.P. Lai, Nicholas J. Ashton et al.|Journal of Neurology Neurosurgery & Psychiatry|2021Cited by 111
Plasma p‐tau231, p‐tau181, <scp>PET</scp> Biomarkers, and Cognitive Change in Older AdultsPierre‐François Meyer, Sylvia Villeneuve, Nicholas J. Ashton et al.|Annals of Neurology|2022Cited by 99